Content area
Full text
GlaxoSmithKline (GSK) is voluntarily recalling almost 600 000 Ventolin (salbutamol) inhalers in the US market due to a product defect, says Reuters reporter Bill Berkrot.
GSK had indicated that it had received "an elevated number of product complaints about a bulging of the outside wrapper, indicating...